Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

634 ARTÍCULOS , VIENDO DEL 226 AL 240

Enhancing global Alzheimer's disease drug outcomes by comprehensive African data integration

Isei MO, Okeowo OM, Okoye CN, Sobodu TO.

J Alzheimers Dis. 2026 Jul;112(2):543-561. doi: 10.1177/13872877261452117. Epub 2026 May 26.

Decoding neuroinflammation: the critical role of NLRP3 inflammasome in Alzheimer's disease

Chaudhary B, Kumari S, Sharma P, Dhapola R, Paidlewar M, Vellingiri B, Medhi B, HariKrishnaReddy D.

Inflammopharmacology. 2026 Jul;34(7):4345-4365. doi: 10.1007/s10787-026-02274-7. Epub 2026 Jun 2.

From capillaries to cognition: decoding neurovascular unit dysfunction and cerebrovascular contributions in Alzheimer's disease

Kumari N, Kumari S, Sharma P, Dhapola R, Paidlewar M, HariKrishnaReddy D.

Biochem Pharmacol. 2026 Sep;251(Pt 1):118107. doi: 10.1016/j.bcp.2026.118107. Epub 2026 Jun 1.

Shared pathophysiology and therapeutic repurposing in Alzheimer's disease and type 2 diabetes: a critical review of convergent mechanisms and clinical challenges

Fu W, Lu R, Wang D, Sang Z.

Bioorg Chem. 2026 Sep 15;180:110044. doi: 10.1016/j.bioorg.2026.110044. Epub 2026 Jun 1.

Ribosome impairment, tau alternative splicing, and stress granules: a convergent axis of neuronal vulnerability driving Alzheimer's disease

Masi M, Oliviero C, Govoni S, Wolozin B, Racchi M, Buoso E.

Eur J Pharmacol. 2026 Jul 15;1030:179033. doi: 10.1016/j.ejphar.2026.179033. Epub 2026 Jun 4.

Bile acids in Alzheimer's disease: a double-edged sword in gut-liver-brain signaling and neurodegeneration

Basri R, Al-Kuraishy HM, Alruwaili M, Al-Gareeb AI, Albuhadily AK, Alexiou A, Papadakis M, Faheem SA, Batiha GE.

Naunyn Schmiedebergs Arch Pharmacol. 2026 Aug;399(11):16841-16859. doi: 10.1007/s00210-026-05516-1. Epub 2026 Jun 9.

Rewiring mTOR signaling in Alzheimer's disease: emerging mTOR modulators beyond oncology

Lohnes BJ, Myskova A, Tyagi A, Hartwig UF, Poddar NK.

Biosci Rep. 2026 Jun 17;46(6):BSR20260203. doi: 10.1042/BSR20260203.

Advances in anti-tau therapeutics for alzheimer's disease: immunotherapy, gene modulation, and combination approaches

Mishra H, Mishra MK.

Mol Biol Rep. 2026 Jun 10;53(1):921. doi: 10.1007/s11033-026-12108-y.

SGLT2 Inhibitors in Alzheimer's Disease: Biochemical Insights and Therapeutic Potential

Mazzeo P, Vietri M, Tecce N, Delizia A, Remondelli V, Ciaglia T, Di Dio A, Corletti L, Pizzuti CG, Pepe G, Stabile E, Correale M, Campiglia P, Miranda MR, Tecce MF, Vestuto V.

Int J Mol Sci. 2026 Jun 3;27(11):5051. doi: 10.3390/ijms27115051.

Next-generation intranasal delivery nano-platforms for targeted brain therapy of Alzheimer's disease

Malaiya A, Kenwat R, Mamgain A, Paliwal SR, Sulakhiya K, Maiti S, Paliwal R.

Nanomedicine (Lond). 2026 Jun;21(12):1775-1795. doi: 10.1080/17435889.2026.2685131. Epub 2026 Jun 16.

Role of suvorexant in Alzheimer's disease: Targeting sleep, orexin signaling, and disease pathophysiology

Ahmed Abbasi A, Norouziyan F, Moradikor N.

J Alzheimers Dis. 2026 Aug;112(4):1700-1716. doi: 10.1177/13872877261461161. Epub 2026 Jun 18.

IL-4 in Alzheimer's Disease-Mechanisms and Therapeutic Potential

Liu G, Li W, Chen J, Xu S, Liu X, Wang Z, Yang Q, Xie A, Du Y.

Mol Neurobiol. 2026 Jun 20;63(1):708. doi: 10.1007/s12035-026-06003-7.

Reprogramming Neuroinflammation: Mitochondrial Targets and Immune Checkpoint Inhibitors in Alzheimer's Disease

Kumar N, Mir PA, Bhutia GT, Chaudhary P, Kaur G, Alam Q, Pawar SD, Gupta SK.

Mol Neurobiol. 2026 Jun 22;63(1):712. doi: 10.1007/s12035-026-05983-w.

Neuroinflammation-centered pathophysiology and therapeutic strategy design in Alzheimer's disease: Cutting-edge developments

Li D, Zhang Z, Lu L, Liu J, Cai W, Hou J, Lu Y, Yu G.

Cell Signal. 2026 Oct;146:112689. doi: 10.1016/j.cellsig.2026.112689. Epub 2026 Jun 26.

From synapses to tangles: PDE inhibitors as therapeutic modulators in Alzheimer's disease

Bagri K, Damde P, Bhatia A, Deshmukh R.

Eur J Pharmacol. 2026 Jul 15;1030:179084. doi: 10.1016/j.ejphar.2026.179084. Epub 2026 Jun 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias